49 genetic-algorithm-computer-"UCL" Fellowship research jobs at University of Birmingham
Sort by
Refine Your Search
-
over India with Machine Learning’ (HEPPI-ML), which is funded through the ‘Weather and Climate Science for Service Partnership ’ (WCSSP) programme. It is also linked to the National Institute for Health
-
programme and/or specific research project Co-ordinate own work with others to avoid conflict or duplication of effort Knowledge of the protected characteristics of the Equality Act 2010, and how to actively
-
at the University of Birmingham is pleased to offer a Part-Time Research Fellow post funded through the NIHR DEMCOMM Fellowship Programme. This post supports a motivated qualitative researcher to contribute
-
and use resources effectively Contribute to the planning and organising of the research programme and/or research project Co-ordinate own work with others to avoid conflict or duplication of effort DBS
-
emergencies PCOS SEVa – a national programme addressing variation in the quality of care for polycystic ovary syndrome (PCOS) Role Summary Work within specified research grants and contribute to writing bids
-
contribute to the creation of knowledge by undertaking a specified range of activities within an established research programme and/or specific research project. Our international group of highly motivated and
-
to the planning and organising of the research programme and/or specific research project Co-ordinate own work with others to avoid conflict or duplication of effort Knowledge of the protected characteristics
-
to broader management/administration processes Contribute to the planning and organising of the research programme and/or specific research project Co-ordinate own work with others to avoid conflict
-
to the creation of knowledge by undertaking a specified range of activities within an established research programme and/or specific research project. We are looking for up to two Postdoctoral Researchers
-
(HPB). The medical oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor